1. Home
  2. AEVA vs AMPH Comparison

AEVA vs AMPH Comparison

Compare AEVA & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AEVA

Aeva Technologies Inc.

HOLD

Current Price

$24.84

Market Cap

1.3B

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$18.30

Market Cap

971.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEVA
AMPH
Founded
2019
1996
Country
United States
United States
Employees
239
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
971.8M
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
AEVA
AMPH
Price
$24.84
$18.30
Analyst Decision
Strong Buy
Buy
Analyst Count
4
8
Target Price
$26.50
$28.38
AVG Volume (30 Days)
2.1M
644.5K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
N/A
$719,887,000.00
Revenue This Year
$85.37
$6.90
Revenue Next Year
$132.72
$4.64
P/E Ratio
N/A
$130.00
Revenue Growth
N/A
N/A
52 Week Low
$8.83
$16.65
52 Week High
$38.79
$31.26

Technical Indicators

Market Signals
Indicator
AEVA
AMPH
Relative Strength Index (RSI) 71.98 40.00
Support Level $12.37 $17.03
Resistance Level N/A $20.08
Average True Range (ATR) 2.45 0.81
MACD 0.60 -0.21
Stochastic Oscillator 94.44 19.16

Price Performance

Historical Comparison
AEVA
AMPH

About AEVA Aeva Technologies Inc.

Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The 4D LiDAR sensors are designed to detect both velocity and position, supporting perception and decision-making in automated systems. The company operates in North America, EMEA, and Asia. The company's revenue consists of sales of perception solutions or sensing systems and non-recurring engineering services. Geographically, it derives the majority of its revenue from North America.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: